AstraZeneca
-
Approval of AstraZeneca’s Evusheld COVID treatment in Canada is ‘good news,’ experts sayAstraZeneca Canada said in a press release that its Evusheld has received a Notice of Compliance from Health Canada to treat COVID-19 for those aged 12 or older.HealthOct 19, 2022
-
Canada to throw away more than half of expired AstraZeneca vaccine dosesCanada also has yet to explain how it plans to manage millions of doses of both Novavax and Medicago vaccines that the country bought.HealthJul 5, 2022
-
-
Advertisement
-
J&J’s COVID-19 vaccine restricted by FDA due to rare but serious blood clot riskU.S. regulators on Thursday strictly limited who can receive Johnson & Johnson's COVID-19 vaccine due to the ongoing risk of rare but serious blood clots.HealthMay 5, 2022
-
-
Advertisement
-
COVID-19: Booster shot uptake rises in Sask. as province adds 829 new cases, 14 deathsThere were 829 new COVID-19 cases confirmed last week in Saskatchewan with 231 cases found in the Saskatoon zone and 141 in the Regina zone.HealthApr 28, 2022
-
Health Canada OKs AstraZeneca’s Evusheld drug for COVID-19 preventionAstraZeneca's Evusheld contains lab-made antibodies designed to linger in the body for months to contain the virus in case of an infection.CanadaApr 14, 2022
-
-
AstraZeneca forecasts 2022 growth even as COVID revenue wanesWhile sales of COVID-19 products are expected to decline by a low-to-mid 20s percentage this year, Astrazeneca forecast overall revenues to rise by a high teens percentage.ConsumerFeb 10, 2022
-
-
AstraZeneca says it is working on an Omicron vaccine with Oxford"Together with Oxford University, we have taken preliminary steps in producing an Omicron variant vaccine, in case it is needed," a spokesperson for the company said.WorldDec 21, 2021
-
FDA approves 1st COVID-19 antibody drug intended for long-term preventionPeople who could benefit from the antibody drug include cancer patients, organ transplant recipients and people taking immune-suppressing drugs.WorldDec 8, 2021
-
-
Advertisement
-
Omicron variant: AstraZeneca exploring impact on vaccine, antibody cocktailAstraZeneca said that it had developed a vaccine platform to respond quickly to new variants with Oxford University, where its vaccine was created.WorldNov 26, 2021
-
-
Advertisement
-
AstraZeneca says COVID-19 antibody drug 83% effective over six monthsAstraZeneca's treatment is given in one go, as two sequential shots in the arm.HealthNov 18, 2021
Trending
-
What Danielle Smith’s Alberta election win means for the rest of Canada89,290 Read
-
Alberta election: Danielle Smith’s UCP to form next government after tight race45,968 Read
-
200 homes or structures damaged, more in danger from devastating Halifax wildfire11,334 Read
-
Are you a mosquito magnet? The science behind why some people get more bites8,994 Read
-
B.C. woman wins Gloucester cheese-roll, unfazed by knockout: ‘Feels so good’8,862 Read
-
How Nova Scotians are showing heroism and kindness amid devastating wildfires7,188 Read
-
Top Videos
-
Alberta election: Danielle Smith’s UCP to form next government after tight race73,431 Viewed
-
Alberta election: A look back at Danielle Smith and Rachel Notley’s political history54,821 Viewed
-
Decision Alberta: The changing dynamic of the province’s politics18,824 Viewed
-
Nova Scotia wildfire: Raging blaze forces 16,000+ Nova Scotians from their homes6,406 Viewed
-
‘Take Back Alberta’ group backs Smith ahead of provincial election5,845 Viewed
-
Decision Alberta: Voters head to the polls, strong turnout expected3,140 Viewed
-